This is the official Google+ page for Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day.
Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies.
Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com
Note to Users: This page is intended to provide news and updates about our company, and Teva reserves the right to delete any comments that it considers to be inappropriate, abusive or spam.
Adverse events for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details may be found here: http://www.tevapharm.com/en-US/Pages/Contact-Us.aspx
In a career at Teva built up over 11 years advancing through 8 positions, Staci is a strong and creative leader who isn’t afraid to push the boundaries in pharmaceutical IP, emphasizing that “You have to be open to trying things that stretch yourself.” Staci has created a community of experts across her team, with a variety of skill sets and different perspectives that help Teva pursue a creative path in an increasingly complex and continually evolving industry.
Read the full article: http://www.pharmexec.com/pharm-execs-emerging-pharma-leaders-2015?pageID=7
If you have innovations or ideas that will help transform our industry, we want to hear from you. Learn more about our business development activities: http://www.tevapharm.com/…/rd_partners…/business_development
Colleagues at Teva’s Respiratory facility in Waterford, Ireland participated in a week-long challenge to be physically active at least one hour a day for 5 days. Employees collected sponsorships that raised over €2,500 for the Asthma Society and the Cystic Fibrosis ward in the local hospital. The week ended with a fun family fitness event that celebrated the importance of a healthy lifestyle, and Teva’s continued commitment to improving health.
It was also an opportunity to announce Sanara’s investment in the first two early stage companies it will support: Kaleidoscope Medical and MGD. These companies are developing innovative technologies for image-guided minimally invasive therapies and chronic respiratory disease management, respectively.
"Sanara’s first investments serve as an impressive example of the great potential of Israeli entrepreneurs and their ability to bring meaningful solutions to patients through innovation,” stated Erez Vigodman, Teva CEO and President.
Read the full PR: http://sanaraventures.com/news/sanara-ventures-announces-first-two-investments/
Erez Vigodman, Teva CEO and President: "The establishment of Sanara and the unique collaboration with Philips emphasizes Teva's commitment to scientific excellence and innovation in Israel, which will continue to serve as a significant factor in Teva’s business development.”
Learn more: http://sanaraventures.com